FMC Corp. stock steadies around $11 as guidance reset puts earnings path under scrutiny
Published on 08/29/2026 at 12:30 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
FMC Corp. (US3024913036) stock is trading close to $11 on August 29, 2026, after the agricultural science group beat second-quarter 2026 earnings expectations but reduced its full-year revenue and profit guidance.
Q2 2026 earnings beat but revenue drops sharply
In the second quarter of 2026, FMC reported adjusted earnings of $0.26 per share, a decline of 62% compared with the same period a year earlier, but still above the consensus estimate of $0.21 per share per the Q2 2026 results analysis.
Quarterly revenue excluding India came in at $841.4 million in Q2 2026, which was down 20% year over year and 7% below the consensus estimate of $905 million, highlighting pressure from lower pricing and volumes despite some cost relief and currency tailwinds.
The company noted that organic revenue declined 22% in the quarter, while its growth portfolio expanded in mid-single digits, supported by new active ingredients such as Cyazypyr that continue to gain traction in crop protection applications.
2026 guidance lowered as market conditions remain challenging
Alongside the Q2 2026 release, FMC updated its outlook for the full year 2026 and cut its revenue expectations to a range of $3.50 billion to $3.70 billion excluding India, down from the previous guidance range of $3.60 billion to $3.80 billion per the same guidance commentary.
FMC now projects adjusted EBITDA of $620 million to $680 million for 2026, compared with its earlier forecast that was higher before the reset, and sees adjusted earnings for the year between $1.19 and $1.49 per share, which frames a wide range depending on how volumes and pricing develop in the second half of the year.
Free cash flow guidance for 2026 was increased to a band of $75 million to $225 million because it now includes a licensing payment, suggesting that cash generation may be more resilient than the headline revenue trend even as the company works through inventory and end-market normalization.
For the third quarter of 2026, FMC expects revenue excluding India between $840 million and $900 million, adjusted EBITDA between $120 million and $140 million, and adjusted earnings in a range of $0.05 to $0.13 per share; for the fourth quarter it forecasts revenue excluding India of $1.06 billion to $1.20 billion, adjusted EBITDA of $275 million to $315 million, and adjusted earnings between $1.09 and $1.33 per share.
The guidance implies that the second half of 2026 should show a sequential improvement in earnings versus the weak second quarter, with the fourth quarter expected to contribute the bulk of full-year profit if volumes and pricing stabilize as anticipated.
Stock hovers near $11 after mixed reaction to earnings and outlook
Market data as of mid-day on August 29, 2026 show FMC shares trading at $10.94 on the New York Stock Exchange, down 1.26% or $0.14 on the day according to the real-time quote page.
Trading activity has also reflected short-term volatility: on August 28, 2026, FMC shares traded as high as $11.12 and last changed hands at $11.11, with 775,057 shares exchanged, a level 80% below the average daily volume of 3,817,273 shares cited by a recent intraday alert.
Another data point from an international investing portal shows FMC shares at $10.59 at the close of the preceding trading session, underlining that the stock is fluctuating within a tight band around $11 in late August 2026 while investors digest the guidance reset and the sharp year-over-year earnings decline.
The share move also appears in broader market coverage, where performance tables of US stocks with strong daily percentage gains list FMC Corporation among the notable movers, indicating that the stock recently posted a daily rise of 6.29% compared with the prior close in one of the latest sessions per a US market gainers overview.
At a share price around $11, the earnings guidance of $1.19 to $1.49 per share for 2026 suggests that the stock is trading at a forward price-to-earnings multiple in the high single digits, assuming the company delivers near the midpoint of its forecast, which may appeal to value-oriented investors but also reflects the execution risk embedded in the wide guidance range.
Consensus and investor focus on execution in crop protection
Given the sharp 62% year-over-year drop in adjusted earnings per share in Q2 2026 and the 20% revenue decline excluding India, investors are paying close attention to whether FMC can stabilize volumes and pricing across key crop-protection markets in Latin America, North America, and Europe in the coming quarters.
The fact that the $0.26 adjusted EPS still exceeded the $0.21 consensus estimate points to some operational flexibility on costs and currency, but the revenue miss of $841.4 million versus expectations of $905 million underscores that demand normalization and competitive dynamics remain the central challenges for the business.
From a guidance perspective, the reduction of the 2026 revenue range to $3.50 billion to $3.70 billion and the adjusted EBITDA range to $620 million to $680 million sets a more cautious baseline than before, while the raised free cash flow range of $75 million to $225 million indicates management confidence in cash generation aided by licensing income and working capital discipline.
The sequential earnings profile implied by guidance, with Q3 2026 EPS between $0.05 and $0.13 and Q4 2026 EPS between $1.09 and $1.33, means that investors will likely view the upcoming quarters as a test of FMC's ability to convert an expected volume recovery into margin and cash-flow improvement.
In this context, the recent trading pattern around $11 per share, combined with daily percentage moves such as the cited 6.29% gain in one latest session, shows that the market is responsive to incremental news on crop conditions, pricing trends, and any updates to guidance or product performance in the portfolio.
Representative product: Cyazypyr in insect control
One of FMC Corp.'s growth drivers mentioned in the Q2 2026 discussion is Cyazypyr, an active ingredient used in insect control products that is part of the company's broader crop-protection portfolio.
Cyazypyr-based solutions are designed to provide broad-spectrum control of pests in high-value crops, supporting yields and quality while aiming to reduce pest resistance issues, and the mid-single-digit growth reported in the overall growth portfolio points to ongoing adoption across key agricultural regions.
As FMC works through the current downcycle in crop-protection demand, products built around active ingredients like Cyazypyr are likely to remain central to its strategy, given their role in supporting farmers' productivity and justifying premium pricing even when broader market volumes are under pressure.
FMC Corp. shares around $11 on NYSE
FMC Corp. shares are listed on the New York Stock Exchange under the ticker FMC and, based on the intraday quote of $10.94 as of 12:09 p.m. ET on August 29, 2026, the stock is trading close to the $11 level in a market that has recently seen daily swings including a 4.2% intraday rise to $11.12 and a gain of 6.29% in one of the latest sessions highlighted in US performance tables.
Fact box
Company: FMC Corp.
ISIN: US3024913036
Ticker: FMC
Exchange: NYSE
Price (as of August 29, 2026, 12:09 p.m. ET): $10.94 USD
Sector / Industry: Materials / Agricultural chemicals
